Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Obs and Gynae
    • Cesarean Section...

    Cesarean Section raises Risk for Postpartum Venous Thromboembolism : CHEST Study

    Written by supriya kashyap kashyap Published On 2016-09-23T16:34:39+05:30  |  Updated On 23 Sept 2016 4:34 PM IST
    Cesarean Section raises Risk for Postpartum Venous Thromboembolism : CHEST Study

    Women are four times more likely to suffer a VTE after a cesarean section compared to a vaginal birth, according to a new study in CHEST®.


    Roughly one third of all births in Europe and North America now occur via cesarean section (CS). Following any birth, women are at an increased risk for a venous thromboembolism (VTE), but it’s believed that CS leaves women more vulnerable to VTE, blood clots, than vaginal delivery (VD). A new study published in CHEST determined that there is a link between CS and an increased absolute risk of VTE, including pulmonary embolism and deep vein thrombosis. Investigators found that CS was associated with a higher rate of overall VTE risk, with emergency CS associated with the greatest risk.


    This comprehensive analysis systematically reviewed 60 authoritative studies related to postpartum VTE outcomes. Investigators found that CS carries a fourfold greater VTE risk than VD. “We found that CS is an important independent risk factor for the development of VTE in the postpartum period and that approximately three VTE will occur for everything 1,000 CS performed, with greater risks for nonscheduled emergency CS,” said lead investigator Marc Blondon, MD, Division of Angiology and Hemostasis, Geneva University Hospitals, Geneva Switzerland. These risks were largely independent of other factors like maternal age and body mass index.


    Pregnant women become more susceptible to VTE due to a variety of factors, including venous stasis and trauma associated to delivery. Also, hemostatic changes drive increases in some coagulation factors, while decreasing bleeding inhibitors, but for some reason these changes seem to be worse for women who deliver via CS. “In the postpartum period specifically, women following CS exhibit greater activation of coagulation than women following VD, as reflected by greater D-dimer levels,” explained Dr. Blondon. D dimer levels indicate that blood clots may be forming or breaking down in the body. “This outcome may be a result of the conditions leading to the CS or to the procedure itself, similar to the increased VTE risk following non-obstetric surgery. Furthermore, physical activity is reduced following CS compared with following VD, with delayed recovery of mobility occurring in the first two days following delivery.”


    As with many non-obstetric surgical procedures, thromboprophylaxis, or preventive measures taken to try and stop VTE before it happens, is commonly employed to try and minimize risk; however, researchers found little evidence on the use of thromboprophylaxis after CS. “Thromboprophylaxis seems widely underutilized in the United States: it is prescribed in 25% of women following CS (mainly compression stockings with less than 3% given heparin prescriptions),” stated Dr. Blondon. “It is estimated that 75% of women following CS do not receive any prophylaxis in the postpartum period. This scenario may arise from a lack of recognition by care providers of the risk of VTE following CS.”


    Investigators also recommended against compression ultrasound when CS patients without symptoms of VTE are discharged from the hospital because their research indicated that it was not useful in catching postpartum DVT.


    This new study helps shed some light on VTE risks associated with CS. Practitioners should be aware of the risks and further research is needed to plot the best course of action and inform future guidelines concerning thromboprophylaxis.


    “Preventing postpartum VTE following CS may lead to an important reduction of its associated morbidity and mortality from a public health perspective,” concluded Dr. Blondon. “In this setting, further observational studies and randomized trials are needed to better appreciate the risks of VTE in specific groups following CS and to define the efficacy and safety of thromboprophylaxis.”


    You can read the full article by clicking on the following link :


    Marc Blondon, Alessandro Casini, Kara K. Hoppe, Françoise Boehlen, Marc Righini, Nicholas L. Smith. Risks of Venous Thromboembolism After Cesarean Sections: A Meta-Analysis. Chest, 2016; 150 (3): 572 DOI:10.1016/j.chest.2016.05.021

    Cesarean sectionCHESTDivision of Angiology and HemostasisGeneva University HospitalsMarc BlondonThromboprophylaxisvaginal deliveryVDvenous thromboembolismVTE

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok